Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NormoFlora-BV
- Development stage
- Unknown
- Lead developer
- MMC Pharmaceuticals
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
NormoFlora-BV is a probiotic nutraceutical developed by MMC Pharmaceuticals for the management of bacterial vaginosis (BV) and the maintenance of urogenital health. Formulated as oral capsules, it typically contains specific strains of beneficial bacteria, such as *Lactobacillus rhamnosus* and *Lactobacillus reuteri*. These probiotics work by colonizing the vaginal epithelium and producing lactic acid, which lowers the vaginal pH to an acidic level (typically <4.5). This acidic environment inhibits the overgrowth of anaerobic pathogens like *Gardnerella vaginalis* and *Atopobium vaginae*, which are characteristic of dysbiosis in BV. NormoFlora-BV is used to restore a healthy vaginal microbiome, often as an adjunct to antibiotic therapy or to prevent recurrent infections in gynecological and urological contexts.
- Brand names
- NormoFlora-BV
- Other names
- NormoFlora-BV Capsules
Beyond the preview
Go deeper on NormoFlora-BV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NormoFlora-BV.